$CYTOF News
Last published 1y ago
- 1y agoCYTOFAltamira Therapeutics Announces Collaboration on Circular RNA DeliveryGlobeNewswireHamilton, May 27, 2025 (GLOBE NEWSWIRE) -- Exploring use of Altamira's RNA nanoparticles in conjunction with circular RNA payloads Project collaboration partner will have option to negotiate licensing agreement
- 1y agoCYTOFAltamira Therapeutics Provides Business Update, Reports Full Year 2024 Financial ResultsGlobeNewswireHamilton, Bermuda, April 30, 2025 (GLOBE NEWSWIRE) -- Management to host conference call today, April 30, at 8:00 a.m. EDTRNA delivery business progressing with platform development, new applications and
- 1y agoCYTOFAltamira Therapeutics to Host Full Year 2024 Financial Results and Business Update Call on April 30, 2025GlobeNewswireHamilton, Bermuda, April 25, 2025 (GLOBE NEWSWIRE) -- Altamira Therapeutics Ltd. ("Altamira" or the "Company") (OTCQB:CYTOF), a company dedicated to developing and commercializing RNA delivery
- 1y agoCYTOFAltamira Announces Notice of Allowance from USPTO for Bentrio Nasal Spray PatentGlobeNewswireHamilton, March 07, 2025 (GLOBE NEWSWIRE) -- Altamira Therapeutics Ltd. (OTCQB:CYTOF) today announced that the U.S. Patent and Trademark Office ("USPTO") has issued a Notice of Allowance for a patent
- 1y agoCYTOFAltamira Therapeutics Announces Collaboration on Radiopharmaceutical Targeting StrategiesGlobeNewswireHamilton, Bermuda, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Exploring use of Altamira's RNA nanoparticles in conjunction with radiopharmaceutical cancer treatment Project collaboration partner will have option to negotiate
- 1y agoCYTOFAltamira Therapeutics Announces Successful Nanoparticle-Based Delivery of Circular RNAGlobeNewswireHamilton, Bermuda, Dec. 31, 2024 (GLOBE NEWSWIRE) -- Further proof of great versatility of Altamira's platform for extrahepatic RNA deliveryCircular mRNA significantly increasing protein expression vs. linear mRNAFiled
- 1y agoCYTOCYTOFAltamira Therapeutics Announces Transition from NASDAQ to OTC MarketsGlobeNewswireHAMILTON, BERMUDA, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Trading to continue under ticker symbol "CYTOF"No reverse stock split planned Altamira Therapeutics Ltd. ("Altamira" or the "Company") (OTCQB:CYTOF), a company